Workshop programme

Tuesday 24 May

Cardiometabolic Risk and Atherosclerosis: from ectopic fat to novel therapies

Diabetes care: Changing the focus from treat to target to treat to benefit
Giorgio Sesti, Roma, Italy
Does the location of ectopic fat matter for CVD risk
Michael Roden, Düsseldorf, Germany

Tuesday 24 May

Endothelial cell biology in atherosclerosis

Cell metabolism in endothelial cells
Carlo Patrono, Roma, Italy
Genome-wide regulation of microRNAs in endothelial cells
Minna Kaikkonen-Maatta, Kuopio, Finland

Monday 23 May

Environment and cardiovascular risk

Dietary components and patterns as determinants of cardiovascular risk
Alice Lichtenstein, Boston, USA
Environment
Thomas Münzel, Germany
Exercise and cardiovascular disease in 2022: When, who and how?
Patrick Schrauwen, Maastricht, The Netherlands

Wednesday 25 May

Imaging guided management

Imaging for plaque progression
Steve Nicholls, Australia
Imaging guided prevention: Hype or real?
Michael Blaha, Baltimore, USA

Tuesday 24 May

Metabolism/regulation of ApoB containing lipoproteins

Intracellular regulation of lipoprotein receptors
Bart van de Sluis, Groningen, The Netherlands
LDL disposal: Receptor vs non-receptor
Marina Cuchel, USA

Monday 23 May

Modulating immune responses in atherosclerosis

Macrophage plasticity in atherosclerotic plaques
Claudia Monaco, UK
Modulating T cell immunity in ASCVD
Ziad Mallat, UK

Wednesday 25 May

New World of targeted therapies (targets, delivery systems,new molecules)

Cell based therapies in atherosclerosis
Megan Levings, Canada
Leveraging on genetics to identify new targets
Sekar Kathiresan, Cambridge, USA

Monday 23 May

Non-classical risk factors? Transitioning from association to casuality

Extracellular vesicles in CVD
Felix Jansen, Germany
Systems biology to estimate cardiovascular risk
Manual Mayr, London, UK

Monday 23 May

PCSK9 – new insights

Deciphering PCSK9 function in the intestine
Bertrand Cariou, Nantes, France
The role of PCSK9 in myocardial lipid metabolism and cardiac biology
Danilo Norata, Milano, Italy

Tuesday 24 May

Plaque stability

Smooth muscle cells plasticity in plaque stability
Marie-Luce Bochaton-Piallat, Geneva, Switzerland
The role of necroptosis in atherogenesis and plaque stability
Katey Rayner, Canada

Monday 23 May

Thrombosis: NETs in CVD

Detailing the role of neutrophils in atherothrombosis
Irene Lang, Vienna, Austria
Platelet activation and inhibition in atherothrombosis and inflammation
Michael Potente, Germany

Wednesday 25 May

Why is age a risk factor?

Cell senescence in atherosclerosis and vascular ageing
Martin Bennett, Cambridge, United Kingdom
Clonal hematopoiesis affecting cardiovascular health
Jose Javier Fuster, Madrid, Spain